Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%) Dr Reddys Laboratories informs about press release
Date: 16-06-2018Dr Reddys Laboratories has informed about the press release on 'Dr. Reddy's Laboratories defends its right to launch Buprenorphine and Naloxone Sublingual Film in the US Market'.
The above information is a part of company’s filings submitted to BSE.